ZB2-96082-57569
2 vaccinations
3 coded responses
5 check-ins
2 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 959 / CA
- Registered
- 2022-08-30
- Relationship
- Child or adolescent in my care
- Guardian
- 7GB-16686-01842
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-07-20
Dose 1 — Pfizer-BioNTech
-
2022-08-24
Dose 2 — Pfizer-BioNTech
-
2022-08-30
Registered in v-safe
-
2022-09-16
Survey response — day 21, dose 2, dependentMedDRA: SARS-CoV-2 test positive — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVID infection with positive testMedDRA releases: 2024-11 · check-in free text available
-
2022-09-16
Report sent to call center — day 21, dose 2, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-09-19
Call successfulParticipant prefers to complete VAERS report online
- 2022-09-28
-
2022-10-05
Survey response — day 42, dose 2, dependentMedDRA: Productive cough, Respiratory tract congestion — Feeling: FairFree text: Productive cough and congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-11-23
-
2023-02-22
Survey response — 6 months, dose 2, dependentMedDRA: Nasopharyngitis — Feeling: FairMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-20 | Pfizer-BioNTech | No |
| 2 | 2022-08-24 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 12 — day 21, dose 2, dependent
Symptoms: COVID infection with positive test
Release 12 — day 42, dose 2, dependent
Symptoms: Productive cough and congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release